1.
Era N, Mukherjee S, Saha B, Tripathi SK. Monitoring cutaneous adverse drug reactions in patients on TDF+3TC+EFV: a single centre experience. Int J Basic Clin Pharmacol [Internet]. 2017 May 23 [cited 2025 Oct. 9];6(6):1467-71. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1633